Working… Menu

A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System (FREEDOM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01775397
Recruitment Status : Terminated (Study terminated due to difficulty in enrollment)
First Posted : January 25, 2013
Last Update Posted : June 4, 2014
Cubist Pharmaceuticals LLC
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Europe Ltd. )

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 2013
Actual Study Completion Date : April 2013